1)Tsukuma H, Ajiki W and Oshima A:Cancer incidence in Japan. In:Cancer mortality and morbidity statistics. edited by Tajima K, Kuroishi T, Oshima A, Monograph on cancer research. No 51. Japan Scientific Societies Press, Karger, Tokyo, 2004
2)筧 善行:限局性前立腺癌治療におけるQOL評価.臨放 51:947-952,2006
3)D'Amico A, Whittington R, Malkowicz S, et al:Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:959-974, 1998
4)Jayadevappa R, Chhatre S, Whittington R, et al:Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy. BJU Int 97:955-962, 2006
5)Zelefsky MJ, Fuks Z, Hunt M, et al:High-dose intensity modulated radiation therapy for prostate cancer:early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53:1111-1116, 2002
6)並木俊一,石戸谷滋人,栃木達男,他:限局性前立腺癌に対する放射線療法前後の患者QOL前向き調査―特にIMRTのQOLへの影響について.泌尿器外科 19:981-986,2006
7)Litwin MS, Sadetsky N, Pasta DJ, et al:Bowel function and bother after treatment for early stage prostate cancer:a longitudinal quality of life analysis from CaPSURE. J Urol 172:515-519, 2004
8)吉田賢史,平塚純一,常 義政,他:限局性前立腺癌に対する高線量率組織内照射後のHealth-Related Quality of Life変化の短期的調査―根治的前立腺全摘術との比較を交え.日放腫会誌 18:99-106,2006
9)常 義政,藤澤正人:前立腺全摘術(RRP)と高線量率組織内照射(HDR-Brachytherapy)後のQOLの評価.西日泌尿 66:249-254,2004
10)Miller DC, Sanda MG, Dunn RL, et al:Long-term outcomes among localized prostate cancer survivors:health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol 23:2772-2780, 2005
11)橋根勝義,沼田幸作,小泉貴裕,他:前立腺癌患者に対する手術および放射線治療後のQOLの評価.日泌尿会誌 96:495-502,2005
12)Pickles T, Agranovich A, Berthelet E, et al:Testosterone recovery following prolonged adjuvant androgen ablation for prostate cancer. Cancer 94:362-367, 2002
13)Wei JT, Dunn RL, Litwin MS, et al:Development and validation of the expanded prostate cancer index composite(EPIC)for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56:899-905, 2000
14)Wei JT, Dunn RL, Sandler HM, et al:Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 20:557-566. 2002
15)Hollenbeck BK, Dunn RL, Wei JT, et al:Neoadjuvant hormonal therapy and older age are associated with adverse sexual health-related quality-of-life outcome after prostate brachytherapy. Urology 59:480-484, 2002